{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:47:45Z","timestamp":1789498065005,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82073345"],"award-info":[{"award-number":["NSFC82073345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH155"],"award-info":[{"award-number":["ZR2023QH155"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022ZD16"],"award-info":[{"award-number":["ZR2022ZD16"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023\\u202FM742159"],"award-info":[{"award-number":["2023\\u202FM742159"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lungcan.2024.107959","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T21:01:30Z","timestamp":1726779690000},"page":"107959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A biomarker exploration in small-cell lung cancer for brain metastases risk and prophylactic cranial irradiation therapy efficacy"],"prefix":"10.1016","volume":"196","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaohui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxiang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2024.107959_b0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.6004\/jnccn.2013.0011","article-title":"Small cell lung cancer","volume":"11","author":"Kalemkerian","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.lungcan.2024.107959_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-24223-1_1","article-title":"Lung Cancer Statistics","volume":"893","author":"Torre","year":"2016","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107959_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107959_b0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1102\/1470-7330.2011.0036","article-title":"Staging and imaging of small cell lung cancer","volume":"11","author":"Kalemkerian","year":"2012","journal-title":"Cancer Imaging"},{"issue":"9","key":"10.1016\/j.lungcan.2024.107959_b0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrclinonc.2017.71","article-title":"Unravelling the biology of SCLC: implications for therapy","volume":"14","author":"Sabari","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.lungcan.2024.107959_b0030","doi-asserted-by":"crossref","unstructured":"Nugent J. L., Bunn P. A., Jr., Matthews M. J., Ihde D. C., Cohen M. H., Gazdar A. and Minna J. D., CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer, 1979. 44(5): p. 1885-93.","DOI":"10.1002\/1097-0142(197911)44:5<1885::AID-CNCR2820440550>3.0.CO;2-F"},{"issue":"9\u201310","key":"10.1016\/j.lungcan.2024.107959_b0035","first-page":"811","article-title":"Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation","volume":"65","author":"Komaki","year":"1981","journal-title":"Cancer Treat Rep"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107959_b0040","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/1097-0142(19821201)50:11<2433::AID-CNCR2820501131>3.0.CO;2-E","article-title":"Intracranial metastases in small cell carcinoma of the lung: correlation of clinical and autopsy findings","volume":"50","author":"Hirsch","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2024.107959_b0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0169-5002(02)00072-7","article-title":"Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease?","volume":"37","author":"Faldum","year":"2002","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107959_b0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2478\/v10019-012-0007-1","article-title":"Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting","volume":"46","author":"Lekic","year":"2012","journal-title":"Radiol Oncol"},{"issue":"7563","key":"10.1016\/j.lungcan.2024.107959_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.lungcan.2024.107959_b0060","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.lungcan.2024.107959_b0065","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.lungcan.2024.107959_b0070","doi-asserted-by":"crossref","unstructured":"Auperin A., Arriagada R., Pignon J. P., Le Pechoux C., Gregor A., Stephens R. J., et al., Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med, 1999. 341(7): p. 476-84.","DOI":"10.1056\/NEJM199908123410703"},{"key":"10.1016\/j.lungcan.2024.107959_b0075","doi-asserted-by":"crossref","unstructured":"Fruh M., De Ruysscher D., Popat S., Crino L., Peters S., Felip E. and Group Esmo Guidelines Working, Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2013. 24 Suppl 6: p. vi99-105.","DOI":"10.1093\/annonc\/mdt178"},{"issue":"4","key":"10.1016\/j.lungcan.2024.107959_b0080","doi-asserted-by":"crossref","first-page":"e201929","DOI":"10.1001\/jamanetworkopen.2020.1929","article-title":"Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation","volume":"3","author":"Pezzi","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.lungcan.2024.107959_b0085","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/j.clon.2021.03.018","article-title":"Utility of Prophylactic Cranial Irradiation for Limited Stage Small Cell Lung Cancer in the Modern Era with Magnetic Resonance Imaging Surveillance","volume":"33","author":"Ghanta","year":"2021","journal-title":"Clin Oncol (r Coll Radiol)"},{"key":"10.1016\/j.lungcan.2024.107959_b0090","first-page":"43","article-title":"Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre","volume":"30","author":"Yan","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107959_b0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12931-022-02196-2","article-title":"Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study","volume":"23","author":"Chen","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.lungcan.2024.107959_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.833478","article-title":"Benefits of Prophylactic Cranial Irradiation in the MRI Era for Patients With Limited Stage Small Cell Lung Cancer","volume":"12","author":"Qi","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107959_b0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.2008.17.0746","volume":"27","author":"Slotman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2024.107959_b0110","doi-asserted-by":"crossref","unstructured":"Lee J. S., Umsawasdi T., Lee Y. Y., Barkley H. T., Jr., Murphy W. K., Welch S. and Valdivieso M., Neurotoxicity in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys, 1986. 12(3): p. 313-21.","DOI":"10.1016\/0360-3016(86)90344-5"},{"issue":"13","key":"10.1016\/j.lungcan.2024.107959_b0115","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1158\/1078-0432.CCR-17-2310","article-title":"Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients","volume":"24","author":"Yang","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107959_b0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41598-017-00520-1","article-title":"Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types","volume":"7","author":"Shu","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.lungcan.2024.107959_b0125","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4143\/crt.2021.963","article-title":"Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation","volume":"54","author":"Wei","year":"2022","journal-title":"Cancer Res Treat"},{"issue":"15","key":"10.1016\/j.lungcan.2024.107959_b0130","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107959_b0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"issue":"23","key":"10.1016\/j.lungcan.2024.107959_b0140","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1093\/bioinformatics\/btu549","article-title":"FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution","volume":"30","author":"Newman","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.lungcan.2024.107959_b0145","doi-asserted-by":"crossref","unstructured":"Riaz N., Havel J. J., Makarov V., Desrichard A., Urba W. J., Sims J. S., et al., Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell, 2017. 171(4): p. 934-949 e16.","DOI":"10.1016\/j.cell.2017.09.028"},{"key":"10.1016\/j.lungcan.2024.107959_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.608742","article-title":"Genomic Profiling Reveals the Molecular Landscape of Gastrointestinal Tract Cancers in Chinese Patients","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107959_b0155","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the Analysis of Survival Data in the Presence of Competing Risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"issue":"446","key":"10.1016\/j.lungcan.2024.107959_b0160","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107959_b0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/annonc\/mdu504","article-title":"Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing","volume":"26","author":"Sun","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2024.107959_b0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2017.11.022","article-title":"Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancer","volume":"115","author":"Liu","year":"2018","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107959_b0175","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1158\/0008-5472.CAN-12-1321","article-title":"Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors","volume":"73","author":"Wakefield","year":"2013","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"10.1016\/j.lungcan.2024.107959_b0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000313697","article-title":"NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer","volume":"78","author":"Puvvada","year":"2010","journal-title":"Oncology"},{"issue":"23","key":"10.1016\/j.lungcan.2024.107959_b0185","doi-asserted-by":"crossref","first-page":"12954","DOI":"10.1128\/JVI.01601-07","article-title":"Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer\/Bcl-3 complexes","volume":"81","author":"Thornburg","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.lungcan.2024.107959_b0190","article-title":"Role of Bcl-3 in solid tumors","author":"Melendez-Zajgla Vilma Maldonado and Jorge","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lungcan.2024.107959_b0195","series-title":"Selective activation of NF-kB subunits in human breast cancer: potential roles for NF-kB2\/p52 and for Bcl-3","author":"Cogswell","year":"2000"},{"issue":"4","key":"10.1016\/j.lungcan.2024.107959_b0200","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0092-8674(00)81037-5","article-title":"Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules","volume":"84","author":"Belmont","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107959_b0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1074\/mcp.M200055-MCP200","article-title":"Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas","volume":"2","author":"Chen","year":"2003","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"10.1016\/j.lungcan.2024.107959_b0210","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1073\/pnas.0806514106","article-title":"Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation","volume":"106","author":"Salvesen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.lungcan.2024.107959_b0215","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s13277-013-0882-0","article-title":"Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer","volume":"34","author":"Ke","year":"2013","journal-title":"Tumour Biol"},{"issue":"7336","key":"10.1016\/j.lungcan.2024.107959_b0220","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7","volume":"471","author":"Wertz","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.lungcan.2024.107959_b0225","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/35103059","article-title":"CHK2 kinase\u2013a busy messenger","volume":"2","author":"Bartek","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107959_b0230","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","article-title":"Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2","volume":"8","author":"Bychkovsky","year":"2022","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107959_b0235","doi-asserted-by":"crossref","first-page":"e000023","DOI":"10.1136\/esmoopen-2015-000023","article-title":"NTRK gene fusions as novel targets of cancer therapy across multiple tumour types","volume":"1","author":"Amatu","year":"2016","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.lungcan.2024.107959_b0240","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/j.1460-2075.1996.tb00521.x","article-title":"A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases","volume":"15","author":"Joukov","year":"1996","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107959_b0245","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","article-title":"Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)","volume":"95","author":"Achen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.lungcan.2024.107959_b0250","first-page":"727","article-title":"Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer","volume":"116","author":"Li","year":"2003","journal-title":"Chin Med J (engl)"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107959_b0255","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2006.02.018","article-title":"The VEGF-C\/Flt-4 axis promotes invasion and metastasis of cancer cells","volume":"9","author":"Su","year":"2006","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.lungcan.2024.107959_b0260","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107959_b0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2009.03.038","article-title":"Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer","volume":"283","author":"Shibata","year":"2009","journal-title":"Cancer Lett"},{"issue":"23","key":"10.1016\/j.lungcan.2024.107959_b0270","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"issue":"10212","key":"10.1016\/j.lungcan.2024.107959_b0275","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2024.107959_b0280","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz071.007","article-title":"ADRIATIC: A phase III trial of durvalumab \u00b1 tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer","volume":"30","author":"Senan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2024.107959_b0285","doi-asserted-by":"crossref","unstructured":"David R. Spigel Ying Cheng, Byoung Chul Cho, Konstantin K. Laktionov, Jian Fang, Yuanbin Chen, Yoshitaka Zenke, Ki Hyeong Lee, Qiming Wang, Alejandro Navarro, and Reyes Bernabe Caro Eva Lotte Buchmeier, John W. C. Chang, Isamu Okamoto, Sema Sezgin Goksu, Andrzej Badzio, Bethany Gill, Hema Gowda, Haiyi Jiang, Suresh Senan, ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC). Journal of Clinical Oncology, 2024. 42.","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA5"},{"issue":"15","key":"10.1016\/j.lungcan.2024.107959_b0290","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1158\/1078-0432.CCR-19-1361","article-title":"Wake Up and Smell the Fusions: Single-Modality Molecular Testing Misses Drivers","volume":"25","author":"Davies","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107959_b0295","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1002\/ctm2.1221","article-title":"Early diagnosis of brain metastases using cerebrospinal fluid cell-free DNA-based breakpoint motif and mutational features in lung cancer","volume":"13","author":"Qin","year":"2023","journal-title":"Clin Transl Med"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224004938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224004938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:20:50Z","timestamp":1778505650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224004938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"alternative-id":["S0169500224004938"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107959","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A biomarker exploration in small-cell lung cancer for brain metastases risk and prophylactic cranial irradiation therapy efficacy","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107959"}}